These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26320506)

  • 21. The value of prognostic factors in Chinese patients with small cell lung cancer: A retrospective study of 999 patients.
    Hong X; Xu Q; Yang Z; Wang M; Yang F; Gao Y; Zhou F; Wang L; Liu B; Chen G
    Clin Respir J; 2018 Feb; 12(2):433-447. PubMed ID: 27460525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.
    Fan G; Zhang K; Ding J; Li J
    Oncotarget; 2017 May; 8(20):33922-33932. PubMed ID: 28430611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Prognostic Value of HER2-Positive Circulating Tumor Cells in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Wang CH; Chang CJ; Yeh KY; Chang PH; Huang JS
    Clin Breast Cancer; 2017 Aug; 17(5):341-349. PubMed ID: 28347604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter to the Editor: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".
    Nicolazzo C; Raimondi C; Loreni F; Gazzaniga P; Gradilone A
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer.
    Massard C; Borget I; Le Deley MC; Taylor M; Gomez-Roca C; Soria JC; Farace F
    Eur J Cancer; 2012 Jun; 48(9):1354-62. PubMed ID: 22370181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between circulating endothelial progenitor cells and serum carcinoembryonic antigen level in colorectal cancer.
    Li Y; Liu J; Zhao Z; Wen L; Li H; Ren J; Liu H
    Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):307-312. PubMed ID: 29377980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy.
    Mehran R; Nilsson M; Khajavi M; Du Z; Cascone T; Wu HK; Cortes A; Xu L; Zurita A; Schier R; Riedel B; El-Zein R; Heymach JV
    Cancer Res; 2014 May; 74(10):2731-41. PubMed ID: 24626092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of circulating endothelial cells in non-small cell lung cancer patients: a systematic review and meta-analysis.
    Liu Y; Yuan D; Ye W; Lv T; Song Y
    Transl Lung Cancer Res; 2015 Oct; 4(5):610-8. PubMed ID: 26629430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reply to the Letter to the Editor by C. Nicolazzo et al.: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".
    Alama A; Coco S; Vanni I; Grossi F
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of serum human epithelial growth factor receptor 2 extracellular domain and circulating tumor cells in evaluating therapeutic response in advanced gastric cancer].
    Li Y; Peng Z; Zhang X; Gong J; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Nov; 20(11):1293-1299. PubMed ID: 29178102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study.
    Ahmed FW; Rider R; Glanville M; Narayanan K; Razvi S; Weaver JU
    Cardiovasc Diabetol; 2016 Aug; 15(1):116. PubMed ID: 27561827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
    Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
    Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of circulating tumor cells in patients with small cell lung cancer.
    Naito T; Tanaka F; Ono A; Yoneda K; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Kenmotsu H; Shukuya T; Kaira K; Koh Y; Endo M; Hasegawa S; Yamamoto N
    J Thorac Oncol; 2012 Mar; 7(3):512-9. PubMed ID: 22258473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value and Clinicopathology Significance of MicroRNA-200c Expression in Cancer: A Meta-Analysis.
    Wu J; Fang Z; Xu J; Zhu W; Li Y; Yu Y
    PLoS One; 2015; 10(6):e0128642. PubMed ID: 26035744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
    Wu B; Sun C; Feng F; Ge M; Xia L
    J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis.
    Zhou Y; Bian B; Yuan X; Xie G; Ma Y; Shen L
    PLoS One; 2015; 10(6):e0130873. PubMed ID: 26098665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
    Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
    BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating tumor cells as a potential biomarker in diagnosis of lung cancer: a systematic review and meta-analysis.
    Huang H; Shi Y; Huang J; Wang X; Zhang R; Chen H
    Clin Respir J; 2018 Feb; 12(2):639-645. PubMed ID: 27778482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.